Aurinia Pharmaceuticals (AUPH) grants PSUs and stock options to CFO
Rhea-AI Filing Summary
Hearne Michael S reported acquisition or exercise transactions in this Form 4 filing.
Aurinia Pharmaceuticals Inc. reported that Chief Financial Officer Michael S. Hearne received new equity compensation awards. He was granted 116,144 performance stock units, each representing a contingent right to receive one common share, and 70,230 employee stock options.
The PSUs vest in multiple tranches based on Aurinia’s share price performance and time-based conditions, while the options have a strike price of $15.28 per share and expire on May 18, 2036. These are compensation-related grants rather than open-market share purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (right to buy) | 70,230 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 116,144 | $0.00 | $0.00 |
Footnotes (2)
- F1. Each performance stock unit ("PSU") represents a contingent right to receive one common share of the Issuer. 46,820 PSUs vest in four tranches upon the Issuer's common shares achieving four progressively higher target prices, with respective one year retention periods per tranche achievement. 69,324 PSUs vest in two tranches at the three and five year anniversary date of grant if the Issuer's common shares achieve target prices that represent significant increases from the share price on date of grant before the respective vesting date.
- F2. 33% vest on the 1-year anniversary of the grant date, and the remaining 67% vest equally in monthly installments over the following 2 years.
Key Figures
Key Terms
performance stock unit ("PSU") financial
Employee Stock Option (right to buy) financial
vest financial
target prices financial
AI-generated analysis. How Rhea-AI works. Not financial advice.